Impact of hemodialysis dose and frequency on survival of patients on chronic hemodialysis in Lithuania during 1998-2005;Hemodializės dozės ir dažnio reikšmė pacientų, sergančių galutiniu inkstų nepakankamumu bei gydomų hemodializėmis, išgyvenimui Lietuvoje 1998-2005 m.

Medicina

Volumn 46, Issue 8, 2010, Pages 516-521

  Stankuviene, Asta ^a   Žiginskiene, Edita ^a   Kuzminskis, Vytautas ^a   Bumblyte, Inga Arune ^a  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

Hemodialysis; Kt V; Survival

Indexed keywords

EID: 78049486030     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina46080074     Document Type: Article

References (18)

1. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 2002;13(4):1061-6.
2. Charra B. From adequate to optimal dialysis long 3 × 8 hr dialysis: a reasonable compromise. Nefrologia 2005;25 Suppl 2:19-24.
3. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006;69:1222-8.
4. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002;347:2010-9.
5. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002;13:1307-20.
6. Locatelli F, Buoncristiani, Canaud B, Köhler H, Petitclerc T, Zucchelli P. Dialysis dose and frequency. Nephrol Dial Transpl 2005;20:285-96.
7. Hanson J, Hulbert-Shearon T, Ojo AO, Port FK, Wolfe RA, Agodoa LY, et al. Prescription of twice-weekly hemodialysis in the USA. Am J Nephrol 1999;19:625-33.
8. K/DOQI clinical practice guidelines and clinical practice recommendations 2006 updates hemodialysis adequacy peritoneal dialysis adequacy vascular access. Am J Kidney Dis 2006;48 Suppl 1:S1.
9. Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 1981;305:1176-81.
10. European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association. Section II. Haemodialysis adequacy. Nephrol Dial Transplant 2002;17 Suppl 7:S16-31.
11. Port FK, Wolfe RA, Hulbert-Shearon TE, McCullough KP, Ashby VB, Held PJ. High dialysis dose is associated with lower mortality among women but not among men. Am J Kidney Dis 2004;43:1014-23.
12. Couchoud C, Kooman J, Finne P, Leivestad T, Stojceva-Taneva O, Ponikvar JB, et al. From registry data collection to international comparisons: examples of haemodialysis duration and frequency. Nephrol Dial Transplant 2009;24(1): 217-4.
13. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, et al. Survival as an index of adequacy of dialysis. Kidney Int 1992;41:1286-91.
14. Laurent G, Charra B. The results of an 8 h thrice weekly haemodialysis schedule. Nephrol Dial Transplant 1998;13 Suppl 6:125-31.
15. Held, PJ, Levin, NW, Bovbjerg, RR, Pauly MV, Diamond LH. Mortality and duration of hemodialysis treatment. JAMA 1991;265:871-5.
16. Woods JD, Port FK, Stannard D, Blagg CR, Held PJ. Comparison of mortality with home hemodialysis and center hemodialysis: a national study. Kidney Int 1996;49:1464-70.
17. Depner T, Daugirdas J, Greene T. Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int 2004;65(4):1386-94.
18. Cheng YL, Choi KS, Yung CU. Urea kinetics and clinical chemistry parameters in patients on twice-weekly hemodialysis. Hong Kong J Nephrol 2004;6:1.